Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Agilon Health (AGL) Enterprise Value: 2020-2025

Historic Enterprise Value for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to -$310.9 million.

  • Agilon Health's Enterprise Value rose 2088.76% to -$310.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$310.9 million, marking a year-over-year increase of 2088.76%. This contributed to the annual value of -$400.0 million for FY2024, which is 1823.39% up from last year.
  • Agilon Health's Enterprise Value amounted to -$310.9 million in Q3 2025, which was up 2088.76% from -$327.0 million recorded in Q2 2025.
  • Over the past 5 years, Agilon Health's Enterprise Value peaked at -$105.4 million during Q1 2021, and registered a low of -$1.1 billion during Q2 2021.
  • Over the past 5 years, Agilon Health's median Enterprise Value value was -$565.0 million (recorded in 2023), while the average stood at -$643.3 million.
  • As far as peak fluctuations go, Agilon Health's Enterprise Value crashed by 87414.58% in 2021, and later surged by 4863.28% in 2024.
  • Over the past 5 years, Agilon Health's Enterprise Value (Quarter) stood at -$1.0 billion in 2021, then rose by 15.62% to -$877.8 million in 2022, then skyrocketed by 44.28% to -$489.2 million in 2023, then rose by 18.23% to -$400.0 million in 2024, then rose by 22.28% to -$310.9 million in 2025.
  • Its Enterprise Value stands at -$310.9 million for Q3 2025, versus -$327.0 million for Q2 2025 and -$367.1 million for Q1 2025.